AAAAAA

   
Results: 1-8 |
Results: 8
ASSESSMENT OF PLATELET-FUNCTION ASSAYS
Authors: NICHOLSON NS PANZERKNODLE SG HAAS NF TAITE BB SZALONY JA PAGE JD FEIGEN LP LANSKY DM SALYERS AK
Citation: Ns. Nicholson et al., ASSESSMENT OF PLATELET-FUNCTION ASSAYS, The American heart journal, 135(5), 1998, pp. 170-178
ORBOFIBAN IS A NEW ORALLY-ACTIVE ANTIPLATELET AGENT ACTING BY ANTAGONISM OF FIBRINOGEN BINDING
Authors: NICHOLSON NS TAITE BB SZALONY JA SALVERS AK HAAS NF PANZERKNODLE SK ENGLEMAN VW FEIGEN LP PAGE JD SEARLE GD
Citation: Ns. Nicholson et al., ORBOFIBAN IS A NEW ORALLY-ACTIVE ANTIPLATELET AGENT ACTING BY ANTAGONISM OF FIBRINOGEN BINDING, The FASEB journal, 12(5), 1998, pp. 4174-4174
PREVENTION OF VASCULAR THROMBOSIS IN DOGS BY THE ACTIVE METABOLITE OFORBOFIBAN
Authors: SZALONY JA TAITE BB FREDERICK LG SULEYMANOV OD KING LW SALYERS AK NICHOLSON NS
Citation: Ja. Szalony et al., PREVENTION OF VASCULAR THROMBOSIS IN DOGS BY THE ACTIVE METABOLITE OFORBOFIBAN, The FASEB journal, 12(5), 1998, pp. 4175-4175
PROTECTIVE EFFECT OF ORAL XEMILOFIBAN IN ARTERIAL THROMBOSIS IN DOGS - INCREASED ACTIVITY IN COMBINATION WITH ASPIRIN
Authors: FREDERICK LG SULEYMANOV OD SZALONY JA TAITE BB SALYERS AK KING LW FEIGEN LP NICHOLSON NS
Citation: Lg. Frederick et al., PROTECTIVE EFFECT OF ORAL XEMILOFIBAN IN ARTERIAL THROMBOSIS IN DOGS - INCREASED ACTIVITY IN COMBINATION WITH ASPIRIN, Circulation, 98(8), 1998, pp. 813-820
POTENT IN-VITRO AND IN-VIVO INHIBITORS OF PLATELET-AGGREGATION BASED UPON THE ARG-GLY-ASP SEQUENCE OF FIBRINOGEN - (AMINOBENZAMIDINO)SUCCINYL (ABAS) SERIES OF ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONISTS
Authors: ZABLOCKI JA RICO JG GARLAND RB ROGERS TE WILLIAMS K SCHRETZMAN LA RAO SA BOVY PR TJOENG FS LINDMARK RJ TOTH MV ZUPEC ME MCMACKINS DE ADAMS SP MIYANO M MARKOS CS MILTON MN PAULSON S HERIN M JACQMIN P NICHOLSON NS PANZERKNODLE SG HAAS NF PAGE JD SZALONY JA TAITE BB SALYERS AK KING LW CAMPION JG FEIGEN LP
Citation: Ja. Zablocki et al., POTENT IN-VITRO AND IN-VIVO INHIBITORS OF PLATELET-AGGREGATION BASED UPON THE ARG-GLY-ASP SEQUENCE OF FIBRINOGEN - (AMINOBENZAMIDINO)SUCCINYL (ABAS) SERIES OF ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 38(13), 1995, pp. 2378-2394
SC-54684A - AN ORALLY-ACTIVE INHIBITOR OF PLATELET-AGGREGATION
Authors: NICHOLSON NS PANZERKNODLE SG SALYERS AK TAITE BB SZALONY JA HAAS NF KING LW ZABLOCKI JA KELLER BT BROSCHAT K ENGLEMAN VW HERIN M JACQMIN P FEIGEN LP
Citation: Ns. Nicholson et al., SC-54684A - AN ORALLY-ACTIVE INHIBITOR OF PLATELET-AGGREGATION, Circulation, 91(2), 1995, pp. 403-410
EXTENDED INHIBITION OF PLATELET-AGGREGATION WITH THE ORALLY-ACTIVE PLATELET INHIBITOR SC-54684A
Authors: SZALONY JA HAAS NF SALYERS AK TAITE BB NICHOLSON NS MEHROTRA DV FEIGEN LP
Citation: Ja. Szalony et al., EXTENDED INHIBITION OF PLATELET-AGGREGATION WITH THE ORALLY-ACTIVE PLATELET INHIBITOR SC-54684A, Circulation, 91(2), 1995, pp. 411-416
A NEW METHOD FOR MEASUREMENT OF PLASMA-CONCENTRATION OF ORALLY-ACTIVEGLYCOPROTEIN IIB IIIA ANTAGONISTS/
Authors: SALYERS AK SZALONY JA TAITE BB HAAS NF MEHROTRA DV FEIGEN LP NICHOLSON NS
Citation: Ak. Salyers et al., A NEW METHOD FOR MEASUREMENT OF PLASMA-CONCENTRATION OF ORALLY-ACTIVEGLYCOPROTEIN IIB IIIA ANTAGONISTS/, Thrombosis research, 75(4), 1994, pp. 409-417
Risultati: 1-8 |